Literature DB >> 25592615

Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.

Cornelia Pocnet1, Jean-Philippe Antonietti1, Alessia Donati2, Julius Popp2, Jérôme Rossier1, Armin von Gunten2.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) has been defined as a transitional state between normal aging and dementia. In many cases, MCI represents an early stage of developing cognitive impairment. Patients diagnosed with MCI do not meet the criteria for dementia as their general intellect and everyday activities are preserved, although minor changes in instrumental activities of daily living (ADL) may occur. However, they may exhibit significant behavioral and psychological signs and symptoms (BPS), also frequently observed in patients with Alzheimer's disease (AD). Hence, we wondered to what extent specific BPS are associated with cognitive decline in participants with MCI or AD.
METHODS: Our sample consisted of 164 participants, including 46 patients with amnestic (single or multi-domain) MCI and 54 patients with AD, as well as 64 control participants without cognitive disorders. Global cognitive performance, BPS, and ADL were assessed using validated clinical methods at baseline and at two-year follow-up.
RESULTS: The BPS variability over the follow-up period was more pronounced in the MCI group than in patients with AD: some BPS improve, others occur newly or worsen, while others still remain unchanged. Moreover, specific changes in BPS were associated with a rapid deterioration of the global cognitive level in MCI patients. In particular, an increase of euphoria, eating disorders, and aberrant motor behavior, as well as worsened sleep quality, predicted a decline in cognitive functioning.
CONCLUSIONS: Our findings confirm a higher variability of BPS over time in the MCI group than in AD patients. Moreover, our results provide evidence of associations between specific BPS and cognitive decline in the MCI group that might suggest a risk of conversion of individuals with amnestic MCI to AD.

Entities:  

Keywords:  behavioral and psychological symptoms; cognitive level; daily living functioning

Mesh:

Year:  2015        PMID: 25592615     DOI: 10.1017/S104161021400283X

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  6 in total

Review 1.  Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Cutter A Lindbergh; Rodney K Dishman; L Stephen Miller
Journal:  Neuropsychol Rev       Date:  2016-07-08       Impact factor: 7.444

2.  Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.

Authors:  Alyssa N De Vito; Matthew Calamia; Daniel S Weitzner; John P K Bernstein
Journal:  Int J Geriatr Psychiatry       Date:  2018-10-01       Impact factor: 3.485

3.  Clinical and Demographic Profiles of Home Care Patients With Alzheimer's Disease and Related Dementias: Implications for Information Transfer Across Care Settings.

Authors:  Miriam Ryvicker; Yolanda Barrón; Shivani Shah; Stanley M Moore; James M Noble; Kathryn H Bowles; Jacqueline Merrill
Journal:  J Appl Gerontol       Date:  2021-03-20

Review 4.  The power of personality in successful ageing: a comprehensive review of larger quantitative studies.

Authors:  Cornelia Pocnet; Julius Popp; Daniela Jopp
Journal:  Eur J Ageing       Date:  2020-07-19

5.  Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database.

Authors:  Masayo Ogawa; Kazushi Maruo; Daichi Sone; Hiroyuki Shimada; Keisuke Suzuki; Hiroshi Watanabe; Hiroshi Matsuda; Hidehiro Mizusawa
Journal:  Alzheimers Dement (N Y)       Date:  2019-08-02

Review 6.  Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Maria Casagrande; Giuseppe Forte; Francesca Favieri; Ilaria Corbo
Journal:  Int J Environ Res Public Health       Date:  2022-07-11       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.